This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Hepatology
Hepatology
Clinical guidelines on chronic hepatitis B issued by NICE
European Commission approves new twice daily dosing of INCIVO®
Phase III trial of regorafenib in patients with advanced liver cancer
Combination drugs are the future for hepatitis B and C
Incivo® receives positive opinion
Janssen submits marketing authorisation application for Simeprevir
TARGAXAN® 550 launched in the UK
Economist Intelligence Unit report calls for global policy innovation
Treating patients co-infected with genotype-1 chronic hepatitis C virus and HIV
Positive outcomes in largest liver transplant trial to date
Twice-daily INCIVO® in genotype-1 chronic hepatitis C virus
Final Phase IIb interferon-free hepatitis C
« Previous
1
2
3
4
5
…
9
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: